explore -WSS

explore

author：Wikipedia 2025-09-30 14:08:26 - browse：94614

Without question, the new federal law banning surprise billing is achieving its goal of protecting patients from enormous medical bills. But in doing so, the measure, which was initially projected to lower federal spending, appears to be raising costs elsewhere.

The Biden administration’s new progress report on the process for arbitrating disagreements between insurance companies and providers, which covers the first six months of 2023, shows that in over 80% of payment disputes, the arbiter settled on an amount that was more than the median in-network rate for that service. In other words, insurers were ordered to pay more to an out-of-network provider than they’d pay to a contracted one. Not only that, the sheer volume of disputes means the three federal agencies that run the program are devoting much more time to it than expected.

“It raises concerns for folks that envisioned the arbitration process as helping to moderate costs rather than be a tool these companies can leverage to obtain even higher payments,” said Zachary Baron, the director of Georgetown University’s Health Policy and Law Initiative.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

WSS

Patient advocates sound warning on FDA proposal on salt intake

Eye stem cell transplant could help restore vision in injured people

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Ask STAT: What do you want to know about ChatGPT in medicine?

ActiGraph execs on goal of drug approvals with digital endpoints

Death of patient in Alzheimer’s trial raises question of possible risks

focus

explore

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Liz Cheney makes 1st public comment since Trump's election interference indictments

Medical leaders decry Supreme Court decision on affirmative action

The battle over the Brookhaven Landfill on Long Island

23andMe had bad news about my health. I wish a person had delivered it

Baltimore teen accused of firing into crowd during block party mass shooting

Dobbs anniversary: the lost opportunity of abortion as health care

Trump's false claims about Georgia's 2020 election long debunked

hotspot

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Do masks work? RCTs can't tell us

Trump cancels press conference intended to dispute Georgia election interference charges

Gene therapy has helped boys walk. Can scientists keep it that way?

Gene therapy has helped boys walk. Can scientists keep it that way?

Trump's false claims about Georgia's 2020 election long debunked

knowledge

entertainment

explore

hotspot